Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
NovoCure
NVCR
$1.78B
| $8.3M | ﹤0.01% |
531,055
-20,720
| -4% | -$305K |
|
2077
Monarch Casino & Resort
MCRI
$2.24B
| $8.28M | ﹤0.01% |
110,409
+3,047
| +3% | +$211K |
|
2078
Winmark
WINA
$1.25B
| $8.27M | ﹤0.01% |
22,878
+533
| +2% | +$196K |
|
2079
Sana Biotechnology
SANA
$885M
| $8.24M | ﹤0.01% |
823,510
+74,675
| +10% | +$559K |
|
2080
Mission Produce
AVO
$1.13B
| $8.22M | ﹤0.01% |
692,816
+34,778
| +5% | +$371K |
|
|
CLDT
2081
Chatham Lodging
CLDT
$614M
| $8.21M | ﹤0.01% |
811,829
+34,890
| +4% | +$364K |
|
|
MODN
2082
DELISTED
MODEL N, INC.
MODN
| $8.2M | ﹤0.01% |
288,175
+10,301
| +4% | +$272K |
|
2083
United Fire Group
UFCS
$1.34B
| $8.19M | ﹤0.01% |
376,393
+12,803
| +4% | +$285K |
|
2084
Resources Connection
RGP
$153M
| $8.19M | ﹤0.01% |
622,533
+58,003
| +10% | +$775K |
|
2085
Vertex
VERX
$2.17B
| $8.19M | ﹤0.01% |
257,795
+4,926
| +2% | +$133K |
|
|
VZIO
2086
DELISTED
VIZIO Holding Corp.
VZIO
| $8.14M | ﹤0.01% |
743,882
+3,677
| +0.5% | +$33.7K |
|
2087
A10 Networks
ATEN
$2.16B
| $8.11M | ﹤0.01% |
592,453
+28,297
| +5% | +$380K |
|
2088
Blue Bird Corp
BLBD
$2.36B
| $8.1M | ﹤0.01% |
211,263
+3,669
| +2% | +$112K |
|
2089
Coupang
CPNG
$29.5B
| $8.09M | ﹤0.01% |
455,011
+245,027
| +117% | +$4.01M |
|
|
INBX
2090
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $8.09M | ﹤0.01% |
231,434
+1,568
| +0.7% | +$57.2K |
|
2091
Fluence Energy
FLNC
$1.93B
| $8.08M | ﹤0.01% |
466,137
+12,084
| +3% | +$221K |
|
2092
Tarsus Pharmaceuticals
TARS
$2.68B
| $8.07M | ﹤0.01% |
221,997
+3,335
| +2% | +$98.1K |
|
|
NKLA
2093
DELISTED
Nikola Corporation Common Stock
NKLA
| $8.06M | ﹤0.01% |
258,347
+33,194
| +15% | +$713K |
|
2094
Garrett Motion
GTX
$5.71B
| $8.04M | ﹤0.01% |
809,183
+23,005
| +3% | +$212K |
|
|
AAN
2095
DELISTED
The Aaron's Company Inc
AAN
| $8M | ﹤0.01% |
1,067,160
+61,785
| +6% | +$578K |
|
2096
QCR Holdings
QCRH
$1.71B
| $8M | ﹤0.01% |
131,763
+293
| +0.2% | +$16.8K |
|
2097
SAP
SAP
$219B
| $7.98M | ﹤0.01% |
40,918
+10,923
| +36% | +$1.94M |
|
2098
Medifast
MED
$108M
| $7.98M | ﹤0.01% |
208,229
+21,985
| +12% | +$1.06M |
|
2099
Green Dot
GDOT
$754M
| $7.95M | ﹤0.01% |
851,578
+102,503
| +14% | +$903K |
|
2100
iShares MBS ETF
MBB
$38.8B
| $7.92M | ﹤0.01% |
85,695
-8,048
| -9% | -$744K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.